Journal Article

Therapeutic activity of green synthesized selenium nanoparticles from turmeric against cisplatin-induced oxido-inflammatory stress and cell death in mice kidney

Moussa, Mohsen M., Mohamed, Amal H., Abdel Moneim, Ahmed E., Samoul, Feryal A., Habotta, Ola A., ALRashdi, Barakat M., Alrashidi, Saad M., Mohamed, Mazen I., Mohamed, Roaya A., Dawod, Bassel, Ramadan, Shimaa S.

2023

Overview

Cisplatin (CDDP) is a commonly prescribed chemotherapeutic agent; however, its associated nephrotoxicity limits its clinical efficacy and sometimes requires discontinuation of its use. The existing study was designed to explore the reno-therapeutic efficacy of turmeric (Tur) alone or conjugated with selenium nanoparticles (Tur-SeNPs) against CDDP-mediated renal impairment in mice and the mechanisms underlying this effect. Mice were orally treated with Tur extract (200 mg/kg) or Tur-SeNPs (0.5 mg/kg) for 7 days after administration of a single dose of CDDP (5 mg/kg, i.p.). N-acetyl cysteine NAC (100 mg/kg) was used as a standard antioxidant compound. The results revealed that Tur-SeNPs counteracted CDDP-mediated serious renal effects in treated mice. Compared with the controls, Tur or Tur-SeNPs therapy remarkably decreased the kidney index along with the serum levels of urea, creatinine, Kim-1, and NGAL of the CDDP-injected mice. Furthermore, Tur-SeNPs ameliorated the renal oxidant status of CDDP group demonstrated by decreased MDA and NO levels along with elevated levels of SOD, CAT, GPx, GR, GSH, and gene expression levels of HO-1. Noteworthy, lessening of renal inflammation was exerted by Tur-SeNPs via lessening of IL-6 and TNF-α besides down-regulation of NF-κB gene expression in mouse kidneys. Tur-SeNPs treatment also restored the renal histological features attained by CDDP challenge and hindered renal apoptosis through decreasing the Bax levels and increasing Bcl-2 levels. Altogether, these outcomes suggest that the administration of Tur conjugated with SeNPs is effective neoadjuvant chemotherapy to guard against the renal adverse effects that are associated with CDDP therapy.

• Publisher: Portland Press Ltd The Biochemical Society,Portland Press Ltd
• Subject: Acetylcysteine / Animals / Antioxidants / Apoptosis / BAX protein / Bcl-2 protein / Bioavailability / Cancer / Cell death / Cell Death & Injury / Chemotherapy / Cisplatin / Cisplatin - adverse effects / Creatinine / Curcuma / Effectiveness / Enzymes / Fourier transforms / Gene expression / Inflammation / Kidney - pathology / Kidneys / Mice / Nanoparticles / NF-κB protein / Oxidants / Oxidative Stress / Oxidizing agents / Renal function / Selenium / Selenium - metabolism / Selenium - pharmacology / Serum levels / Therapeutics & Molecular Medicine / Toxicity / Tumor necrosis factor-TNF / Tumor necrosis factor-α / Urea